Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma. [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial to evaluate the safety and efficacy of ESO-T01 for relapsed/refractory multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ESO-T01

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Multiple Myeloma | EARLY_Phase 1 | Status: RECRUITING